discovered that ethyl pyruvate (EP) (80), a potent inhibitor of HMGB1, inhibits cell cycle progression, and suppresses the growth and proliferation of liver cancer cells by reducing the expression of HMGB1, RAGE, and serine/threonine kinase (AKT) (81). This evidence concerns the gene HMGB1 and liver cancer.